Recently, Boudewijns et al. proposed a novel therapeutic HBc vaccine that induced a strong polyfunctional cytotoxic T-cell response in mice using yellow fever vaccine as a live-attenuated vector for the expression of the HBc gene [25]. The gene discussed is KRT88P; the disease is viral infectious disease.